Julie Darity was once a contracts administration officer for C.R. Bard Inc., which is a medical device company in New Jersey. Darity exposed a scheme where Bard was pushing brachytherapy seeds for kickbacks. Brachytherapy seeds are not seeds in the traditional sense of the word. They are small pieces of radioactive metal, such as iodine or palladium, which are implanted in the body. Scientists Marie and Pierre Curie first discovered the properties of these metals and their uses, theorizing that "seeds" implanted in the body could help shrink tumors.
The science may not be new, but it is a relatively new treatment method for cancer in the medical field. However, Bard quickly found a way to exploit the treatment method. Bard gave physicians and hospitals kickbacks in the form of grants, marketing assistance, medical equipment, rebates, and conference fees. The kickbacks were in exchange for prescriptions written to patients for the brachytherapy seed treatment. The prescriptions were then submitted to Medicare, in violation of the False Claims Act. Bard ultimately settled in a Georgia federal court for $48.26 million dollars. As the whistleblower who stepped forward to report this fraud, Darity will be awarded $10,134,600.
If you would like more information about whistleblower and qui tam actions, or if you wish to discuss a potential claim, contact a Washington, DC whistleblower lawyer from Chaikin, Sherman, Cammarata & Siegel, P.C. or complete a
free case evaluation form.